<?xml version="1.0" encoding="UTF-8"?>

<ValueSet xmlns="http://hl7.org/fhir">
  <id value="ATCImmunotherapyCLL"/>
  <text>
    <status value="extensions"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet ATCImmunotherapyCLL</b></p><a name="ATCImmunotherapyCLL"> </a><a name="hcATCImmunotherapyCLL"> </a><a name="ATCImmunotherapyCLL-en-US"> </a><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href="CodeSystem-GenericValues.html"><code>https://kip.rkkp.dk/fhir/CodeSystem/GenericValues</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href="CodeSystem-GenericValues.html#GenericValues-none">none</a></td><td>Ingen immunterapi</td><td>None - used to choose none of the available values</td></tr><tr><td><a href="CodeSystem-GenericValues.html#GenericValues-other">other</a></td><td>Andet</td><td>Other - used to choose unspecific value not in a valueset</td></tr></table></li><li>Include these codes as defined in <a href="CodeSystem-ATC.html"><code>https://kip.rkkp.dk/fhir/CodeSystem/ATC</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L04AA34">L04AA34</a></td><td>Alemtuzumab</td><td>L04AA34 - alemtuzumab</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01FA01">L01FA01</a></td><td>Rituximab</td><td>L01FA01 - rituximab</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01FA02">L01FA02</a></td><td>Ofatumumab</td><td>L01FA02 - ofatumumab</td></tr><tr><td><a href="CodeSystem-ATC.html#ATC-L01FA03">L01FA03</a></td><td>Obinutuzumab</td><td>L01FA03 - obinutuzumab</td></tr></table></li></ul></div>
  </text>
  <url value="https://kip.rkkp.dk/fhir/ValueSet/ATCImmunotherapyCLL"/>
  <version value="2.11.4"/>
  <name value="ATCImmunotherapyCLL"/>
  <title value="ATC_CLL_immunterapi"/>
  <status value="active"/>
  <experimental value="true"/>
  <date value="2022-07-13T00:00:00+02:00"/>
  <publisher value="Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S"/>
  <contact>
    <name value="Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S"/>
    <telecom>
      <system value="url"/>
      <value value="https://trifork.com"/>
    </telecom>
    <telecom>
      <system value="email"/>
      <value value="rbk@trifork.com"/>
    </telecom>
  </contact>
  <description value="ATC koder immunterapi - [CLL]"/>
  <compose>
    <include>
      <system value="https://kip.rkkp.dk/fhir/CodeSystem/GenericValues"/>
      <concept>
        <code value="none"/>
        <display value="Ingen immunterapi"/>
      </concept>
      <concept>
        <code value="other"/>
        <display value="Andet"/>
      </concept>
    </include>
    <include>
      <system value="https://kip.rkkp.dk/fhir/CodeSystem/ATC"/>
      <concept>
        <code value="L04AA34"/>
        <display value="Alemtuzumab"/>
      </concept>
      <concept>
        <code value="L01FA01"/>
        <display value="Rituximab"/>
      </concept>
      <concept>
        <code value="L01FA02"/>
        <display value="Ofatumumab"/>
      </concept>
      <concept>
        <code value="L01FA03"/>
        <display value="Obinutuzumab"/>
      </concept>
    </include>
  </compose>
</ValueSet>